|
Saturday, 01 December 2007 |
|
A group of Fosamax lawyers have argued that a judge should grant class action status to the lawsuits they have filed against Merck & Co., the manufacturers of the bone-building drug. The lawyers say that by granting class-action status to the Fosamax lawsuits, it would give a jury an opportunity to decide whether the drug is hazardous to patients’ health and whether Merck was negligent in failing to properly warn them about the risk of Fosamax side effects. |
|
Read more...
|
|
|
Tuesday, 09 October 2007 |
|
A woman in Florida has filed a Fosamax lawsuit against Merck & Co., the manufacturer of the drug. Linda Secrest’s lawsuit alleges that she developed a painful jaw condition known as osteonecrosis of the jaw, or jaw necrosis, after taking Fosamax. |
|
Read more...
|
|
|
Tuesday, 02 October 2007 |
|
The Food and Drug Administration has announced that it will conduct a one year safety review of Fosamax and other similar drugs to investigate their risk of causing an irregular heartbeat. Fosamax is part of a class of drugs known as bisphosphonates, which are designed to treat osteoporosis, Paget’s disease and bone problems caused by advanced cancer. |
|
Read more...
|
|
|
Monday, 27 August 2007 |
|
Seven Texas residents have filed a Fosamax lawsuit against Merck & Co., claiming that the osteoporosis drug caused them to develop permanent bone loss in the jaw. The lawsuit alleges that Fosamax is a defective drug and that Merck bribed doctors to prescribe it despite the risk of Fosamax side effects. |
|
Read more...
|
|
|
Thursday, 26 July 2007 |
|
Four patients have filed Fosamax lawsuits in New Jersey Superior Court against Merck, the manufacturer of the drug. The lawsuits allege that taking Fosamax caused the four individuals to develop osteonecrosis of the jaw (ONJ), a condition that causes the bones of the jaw to decay. |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
| Results 10 - 18 of 23 |